Cargando…

For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission

BACKGROUND: The emergence of oligoclonal bands, proteins differing from those originally identified at diagnosis, has been reported in multiple myeloma patients after high-dose chemotherapy followed by autologous stem cell transplantation and after successful conventional chemotherapy. The clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Luiza Soares Vieira da, Crusoe, Edvan de Queiroz, Souza, Lais Rocha Guimarães de, Chiattone, Carlos Sérgio, Hungria, Vânia Tietsche de Moraes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693271/ https://www.ncbi.nlm.nih.gov/pubmed/29150105 http://dx.doi.org/10.1016/j.bjhh.2017.05.010

Ejemplares similares

Multiple myeloma and central nervous system involvement: experience of a Brazilian center
por: Dias, Ana Luiza Miranda Silva, et al.
Publicado: (2018)

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012
por: Hungria, Vânia Tietsche de Moraes, et al.
Publicado: (2013)

Bilateral breast plasmacytoma: a clinical case report
por: Fischer, Thais Rodrigues da Cunha, et al.
Publicado: (2016)

Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
por: Viol Ferreira Lopes, Maricy Almeida, et al.
Publicado: (2023)

Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
por: Cury, Priscilla Cury de Camargo, et al.
Publicado: (2020)

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
por: de Queiroz Crusoe, Edvan, et al.
Publicado: (2014)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients
por: Maiolino, Angelo, et al.
Publicado: (2021)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
por: Crusoe, Edvan de Queiroz, et al.
Publicado: (2016)

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I
por: Maiolino, Angelo, et al.
Publicado: (2022)

CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil
por: Hungria, Vania, et al.
Publicado: (2023)

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
por: Hungria, Vania, et al.
Publicado: (2020)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Multiple myeloma with Echinococcus granulosus infection diagnosed by detection of oligoclonal bands: A case report
por: Li, Jinghong, et al.
Publicado: (2021)

Absence of B Cells in Brainstem and White Matter Lesions Associates With Less Severe Disease and Absence of Oligoclonal Bands in MS
por: Fransen, Nina L., et al.
Publicado: (2021)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band
por: Vyas, Shikhar G., et al.
Publicado: (2017)

COVID-19 in Multiple Myeloma Patients: Frequencies and Risk Factors for Hospitalization, Ventilatory Support, Intensive Care Admission and Mortality -Cooperative Registry from Grupo Brasileiro De Mieloma Multiplo (GBRAM)
por: Garnica, Marcia, et al.
Publicado: (2021)

Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival
por: Fujisawa, Manabu, et al.
Publicado: (2014)

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis
por: da Gama, Paulo Diniz, et al.
Publicado: (2015)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients
Publicado: (2015)

Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi
por: Berek, Klaus, et al.
Publicado: (2020)

Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma()
por: Crusoé, Edvan de Queiroz, et al.
Publicado: (2021)

In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
por: Bankoti, Jaishree, et al.
Publicado: (2014)

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
por: Leone, Maurizio A., et al.
Publicado: (2013)

Detection of Oligoclonal Ig Bands: Clinical Significance and Trends in Methodological Improvement
por: Trbojevic–Cepe, Milica
Publicado: (2004)

Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases
por: Pannewitz-Makaj, Katharina, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
por: Katsarogiannis, Evangelos, et al.
Publicado: (2023)

P954: MULTIPLE MYELOMA IN LATIN AMERICA CANCER REGISTRY: THE MYLACRE STUDY
por: Hungria, Vania, et al.
Publicado: (2023)

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis
por: Brecht, Isabel, et al.
Publicado: (2012)

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod
por: Okada, Kazumasa, et al.
Publicado: (2018)

Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients
por: Hümmert, Martin W., et al.
Publicado: (2019)

Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis Diagnosis
por: Haddad, Farah, et al.
Publicado: (2022)

Oligoclonal Bands in Multiple System Atrophy: Case Report and Proposed Mechanisms of Immunogenicity
por: Neilson, Lee E., et al.
Publicado: (2022)

Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin
por: Prümmer, Julia K., et al.
Publicado: (2023)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
por: Boufidou, Fotini, et al.
Publicado: (2023)

Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern
por: Zeman, David, et al.
Publicado: (2012)

Comparison of neurophysiological and MRI findings of patients with multiple sclerosis using oligoclonal band technique
por: Ellidag, Hamit Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7v5cqnfvvpgoct9nnte0vele5f